REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Walmark, A.S. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Walmark, A.S. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Walmark, A.S. is based in Czech Republic. The head office is in Trinec. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on July 30, 1990. There are currently 250 - 499 (2025) people employed by Walmark, A.S.. In 2024, the company reported a net sales revenue drop of 9.07%. A negative growth of 16.67% was recorded in its total assets. The enterprise’s net profit margin decreased by 3.54% in 2024.

Headquarters
Oldrichovice 44
Trinec; Moravskoslezsky; Postal Code: 73961

Contact Details: Purchase the Walmark, A.S. report to view the information.

Website: http://www.walmark.cz/

Basic Information
Total Employees:
Purchase the Walmark, A.S. report to view the information.
Registered Capital:
Purchase the Walmark, A.S. report to view the information.
Financial Auditors:
Purchase the Walmark, A.S. report to view the information.
Incorporation Date:
July 30, 1990
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
ACIGI nature, s.r.o.
100%
DH-norm s.r.o.
100%
Idelyn S.R.O.
100%
Company Performance
Financial values in the chart are available after Walmark, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-9.07%▼
Total Operating Revenue
-11.3%▼
Operating Profit
-69.59%▼
EBITDA
-56.65%▼
Net Profit/Loss for the Period
-52.75%▼
Total Assets
-16.67%▼
Total Equity
41.69%▲
Operating Profit Margin
-10.55%▼
Net Profit Margin
-3.54%▼
Return on Equity (ROE)
-57.71%▼
Quick Ratio
-0.05%▼
Cash Ratio
0.06%▲

Similar companies

Zentiva, K.S.
 
Novartis S.R.O.
Teva Czech Industries S.R.O.
 
Novavax Cz A.S.
Hartmann - Rico A.S.
 
Lohmann & Rauscher, S.R.O.
Ferring-Leciva, A.S.
 
Synthon, S.R.O.
Farmak, A.S.
 
Sanaplasma S.R.O.
Arxada Biotec S.R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo